IL-6 signaling regulates small intestinal crypt homeostasis

Journal of Immunology

Volumn 199, Issue 1, 2017, Pages 304-311

  Jeffery, Victoria ^a   Goldson, Andrew J ^b   Dainty, Jack R ^c   Chieppa, Marcello ^d   Sobolewski, Anastasia ^a,b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d National Institute of Gastroenterology S de Bellis   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; STAT3 PROTEIN; IMMUNOGLOBULIN G; STAT3 PROTEIN, MOUSE;

ANTIBODY LABELING; ARTICLE; CELL BUDDING; CELL PROLIFERATION; CONTROLLED STUDY; HOMEOSTASIS; INTESTINE CRYPT; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PANETH CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WNT SIGNALING PATHWAY; ANIMAL; CELL DIFFERENTIATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; SMALL INTESTINE; STEM CELL; WNT SIGNALING;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HOMEOSTASIS; IMMUNOGLOBULIN G; INTERLEUKIN-6; INTESTINAL MUCOSA; INTESTINE, SMALL; MICE; ORGAN CULTURE TECHNIQUES; PANETH CELLS; RECEPTORS, INTERLEUKIN-6; STAT3 TRANSCRIPTION FACTOR; STEM CELLS; WNT SIGNALING PATHWAY;

EID: 85021159149     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600960     Document Type: Article

References (51)

1. Barker, N., J. H. van Es, J. Kuipers, P. Kujala, M. van den Born, M. Cozijnsen, A. Haegebarth, J. Korving, H. Begthel, P. J. Peters, and H. Clevers. 2007. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007.
2. Sato, T., J. H. van Es, H. J. Snippert, D. E. Stange, R. G. Vries, M. van den Born, N. Barker, N. F. Shroyer, M. van de Wetering, and H. Clevers. 2011. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469: 415-418.
3. Reynolds, A., N. Wharton, A. Parris, E. Mitchell, A. Sobolewski, C. Kam, L. Bigwood, A. El Hadi, A. Münsterberg, M. Lewis, et al. 2014. Canonical Wnt signals combined with suppressed TGFb/BMP pathways promote renewal of the native human colonic epithelium. Gut 63: 610-621.
4. Skoczek, D. A., P. Walczysko, N. Horn, A. Parris, S. Clare, M. R. Williams, and A. Sobolewski. 2014. Luminal microbes promote monocyte-stem cell interactions across a healthy colonic epithelium. J. Immunol. 193: 439-451.
5. Brown, S. L., T. E. Riehl, M. R. Walker, M. J. Geske, J. M. Doherty, W. F. Stenson, and T. S. Stappenbeck. 2007. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J. Clin. Invest. 117: 258-269.
6. Pull, S. L., J. M. Doherty, J. C. Mills, J. I. Gordon, and T. S. Stappenbeck. 2005. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA 102: 99-104.
7. Seno, H., H. Miyoshi, S. L. Brown, M. J. Geske, M. Colonna, and T. S. Stappenbeck. 2009. Efficient colonic mucosal wound repair requires Trem2 signaling. Proc. Natl. Acad. Sci. USA 106: 256-261.
8. Ayyaz, A., H. Li, and H. Jasper. 2015. Haemocytes control stem cell activity in the Drosophila intestine. Nat. Cell Biol. 17: 736-748.
9. Jiang, H., P. H. Patel, A. Kohlmaier, M. O. Grenley, D. G. McEwen, and B. A. Edgar. 2009. Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the Drosophila midgut. Cell 137: 1343-1355.
10. Osman, D., N. Buchon, S. Chakrabarti, Y. T. Huang, W. C. Su, M. Poidevin, Y. C. Tsai, and B. Lemaitre. 2012. Autocrine and paracrine unpaired signaling regulate intestinal stem cell maintenance and division. J. Cell Sci. 125: 5944-5949.
11. Grivennikov, S., E. Karin, J. Terzic, D. Mucida, G. Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113.
12. Jin, X., T. A. Zimmers, Z. Zhang, R. H. Pierce, and L. G. Koniaris. 2010. Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut 59: 186-196.
13. Pickert, G., C. Neufert, M. Leppkes, Y. Zheng, N. Wittkopf, M. Warntjen, H. A. Lehr, S. Hirth, B. Weigmann, S. Wirtz, et al. 2009. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206: 1465-1472.
14. Kuhn, K. A., N. A. Manieri, T. C. Liu, and T. S. Stappenbeck. 2014. IL-6 stimulates intestinal epithelial proliferation and repair after injury. PLoS One 9: e114195.
15. Bollrath, J., T. J. Phesse, V. A. von Burstin, T. Putoczki, M. Bennecke, T. Bateman, T. Nebelsiek, T. Lundgren-May, O. Canli, S. Schwitalla, et al. 2009. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15: 91-102.
16. Lee, M. J., J. K. Lee, J. W. Choi, C. S. Lee, J. H. Sim, C. H. Cho, K. H. Lee, I. H. Cho, M. H. Chung, H. R. Kim, and S. K. Ye. 2012. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS One 7: e38801.
17. Mihara, M., M. Hashizume, H. Yoshida, M. Suzuki, and M. Shiina. 2012. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. 122: 143-159.
18. Hunter, C. A., and S. A. Jones. 2015. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16: 448-457.
19. Garbers, C., S. Aparicio-Siegmund, and S. Rose-John. 2015. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition. Curr. Opin. Immunol. 34: 75-82.
20. Scheller, J., A. Chalaris, D. Schmidt-Arras, and S. Rose-John. 2011. The proand anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 1813: 878-888.
21. Jones, S. A., P. J. Richards, J. Scheller, and S. Rose-John. 2005. IL-6 transsignaling: the in vivo consequences. J. Interferon Cytokine Res. 25: 241-253.
22. Sato, T., R. G. Vries, H. J. Snippert, M. van de Wetering, N. Barker, D. E. Stange, J. H. van Es, A. Abo, P. Kujala, P. J. Peters, and H. Clevers. 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459: 262-265.
23. Farin, H. F., W. R. Karthaus, P. Kujala, M. Rakhshandehroo, G. Schwank, R. G. Vries, E. Kalkhoven, E. E. Nieuwenhuis, and H. Clevers. 2014. Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-g. J. Exp. Med. 211: 1393-1405.
24. François, M., E. Birman, K. A. Forner, L. Gaboury, and J. Galipeau. 2012. Adoptive transfer of mesenchymal stromal cells accelerates intestinal epithelium recovery of irradiated mice in an interleukin-6-dependent manner. Cytotherapy 14: 1164-1170.
25. Bernardo, D., S. Vallejo-Díez, E. R. Mann, H. O. Al-Hassi, B. Martínez-Abad, E. Montalvillo, C. T. Tee, A. U. Murugananthan, H. Núñez, S. T. Peake, et al. 2012. IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate. Eur. J. Immunol. 42: 1337-1353.
26. Sommer, J., E. Engelowski, P. Baran, C. Garbers, D. M. Floss, and J. Scheller. 2014. Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis. Int. J. Mol. Med. 34: 651-660.
27. Giraud, A. S., C. Jackson, T. R. Menheniott, and L. M. Judd. 2007. Differentiation of the gastric mucosa IV. Role of trefoil peptides and IL-6 cytokine family signaling in gastric homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1-G5.
28. Sims, N. A., and N. C. Walsh. 2010. GP130 cytokines and bone remodelling in health and disease. BMB Rep. 43: 513-523.
29. Jain, U., Q. Cao, N. A. Thomas, T. M. Woodruff, W. J. Schwaeble, C. M. Stover, and A. W. Stadnyk. 2015. Properdin provides protection from Citrobacter rodentium-induced intestinal inflammation in a C5a/IL-6-dependent manner. J. Immunol. 194: 3414-3421.
30. Palin, K., M. L. Moreau, H. Orcel, A. Duvoid-Guillou, A. Rabié, K. W. Kelley, and F. Moos. 2009. Age-impaired fluid homeostasis depends on the balance of IL-6/IGF-I in the rat supraoptic nuclei. Neurobiol. Aging 30: 1677-1692.
31. Man, A. L., N. Gicheva, and C. Nicoletti. 2014. The impact of ageing on the intestinal epithelial barrier and immune system. Cell. Immunol. 289: 112-118.
32. Man, A. L., E. Bertelli, S. Rentini, M. Regoli, G. Briars, M. Marini, A. J. Watson, and C. Nicoletti. 2015. Age-associated modifications of intestinal permeability and innate immunity in human small intestine. Clin. Sci. 129: 515-527.
33. Becker, C., M. C. Fantini, C. Schramm, H. A. Lehr, S. Wirtz, A. Nikolaev, J. Burg, S. Strand, R. Kiesslich, S. Huber, et al. 2004. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21: 491-501.
34. van Dam, M., J. Müllberg, H. Schooltink, T. Stoyan, J. P. Brakenhoff, L. Graeve, P. C. Heinrich, and S. Rose-John. 1993. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. J. Biol. Chem. 268: 15285-15290.
35. Matthews, J. R., O. J. Sansom, and A. R. Clarke. 2011. Absolute requirement for STAT3 function in small-intestine crypt stem cell survival. Cell Death Differ. 18: 1934-1943.
36. Nguyen, P. M., T. L. Putoczki, and M. Ernst. 2015. STAT3-activating cytokines: a therapeutic opportunity for inflammatory bowel disease? J. Interferon Cytokine Res. 35: 340-350.
37. Aden, K., A. Breuer, A. Rehman, H. Geese, F. Tran, J. Sommer, G. H. Waetzig, T. M. Reinheimer, S. Schreiber, S. Rose-John, et al. 2016. Classic IL-6R signalling is dispensable for intestinal epithelial proliferation and repair. Oncogenesis 5: e270.
38. Sugimoto, K., A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, A. K. Bhan, R. S. Blumberg, R. J. Xavier, and A. Mizoguchi. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118: 534-544.
39. Lindemans, C. A., M. Calafiore, A. M. Mertelsmann, M. H. O'Connor, J. A. Dudakov, R. R. Jenq, E. Velardi, L. F. Young, O. M. Smith, G. Lawrence, et al. 2015. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528: 560-564.
40. Kim, T. H., S. Escudero, and R. A. Shivdasani. 2012. Intact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cells. Proc. Natl. Acad. Sci. USA 109: 3932-3937.
41. Durand, A., B. Donahue, G. Peignon, F. Letourneur, N. Cagnard, C. Slomianny, C. Perret, N. F. Shroyer, and B. Romagnolo. 2012. Functional intestinal stem cells after Paneth cell ablation induced by the loss of transcription factor Math1 (Atoh1). Proc. Natl. Acad. Sci. USA 109: 8965-8970.
42. Farin, H. F., I. Jordens, M. H. Mosa, O. Basak, J. Korving, D. V. Tauriello, K. de Punder, S. Angers, P. J. Peters, M. M. Maurice, and H. Clevers. 2016. Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature 530: 340-343.
43. Simmonds, N., M. Furman, E. Karanika, A. Phillips, and A. W. Bates. 2014. Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children. BMC Gastroenterol. 14: 93.
44. Tanaka, M., H. Saito, T. Kusumi, S. Fukuda, T. Shimoyama, Y. Sasaki, K. Suto, A. Munakata, and H. Kudo. 2001. Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease. J. Gastroenterol. Hepatol. 16: 1353-1359.
45. Mudter, J., and M. F. Neurath. 2007. Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm. Bowel Dis. 13: 1016-1023.
46. Waldner, M. J., and M. F. Neurath. 2014. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. Semin. Immunol. 26: 75-79.
47. Gout, T., A. J. Ostör, and M. K. Nisar. 2011. Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review. Clin. Rheumatol. 30: 1471-1474.
48. Emery, P., E. Keystone, H. P. Tony, A. Cantagrel, R. van Vollenhoven, A. Sanchez, E. Alecock, J. Lee, and J. Kremer. 2008. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann. Rheum. Dis. 67: 1516-1523.
49. Rose-John, S. 2012. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci. 8: 1237-1247.
50. Matsumoto, S., T. Hara, K. Mitsuyama, M. Yamamoto, O. Tsuruta, M. Sata, J. Scheller, S. Rose-John, S. Kado, and T. Takada. 2010. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitisassociated premalignant cancer in a murine model. J. Immunol. 184: 1543-1551.
51. Schaper, F., and S. Rose-John. 2015. Interleukin-6: biology, signaling and strategies of blockade. Cytokine Growth Factor Rev. 26: 475-487.